X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (8705) 8705
Newsletter (415) 415
Newspaper Article (148) 148
Magazine Article (50) 50
Book Chapter (42) 42
Dissertation (22) 22
Transcript (4) 4
Web Resource (3) 3
Book / eBook (1) 1
Conference Proceeding (1) 1
Publication (1) 1
Streaming Video (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
tenofovir (6880) 6880
humans (5585) 5585
female (3093) 3093
male (2885) 2885
infectious diseases (2853) 2853
hiv infections - drug therapy (2668) 2668
adenine - analogs & derivatives (2654) 2654
hiv (2587) 2587
adult (2500) 2500
middle aged (1868) 1868
emtricitabine (1635) 1635
anti-hiv agents - therapeutic use (1624) 1624
tenofovir disoproxil fumarate (1601) 1601
immunology (1589) 1589
pharmacology & pharmacy (1533) 1533
human immunodeficiency virus--hiv (1472) 1472
adenine - therapeutic use (1471) 1471
hepatitis b (1471) 1471
lamivudine (1375) 1375
antiretroviral therapy (1368) 1368
virology (1267) 1267
antiviral agents (1240) 1240
organophosphonates - therapeutic use (1233) 1233
drug therapy (1210) 1210
treatment outcome (1147) 1147
anti-hiv agents - administration & dosage (1129) 1129
hiv infection (1118) 1118
infection (1022) 1022
therapy (985) 985
health aspects (982) 982
antiviral agents - therapeutic use (976) 976
prevention (962) 962
hiv infections - prevention & control (938) 938
anti-hiv agents - adverse effects (933) 933
research (928) 928
hepatitis b, chronic - drug therapy (914) 914
microbiology (896) 896
drug therapy, combination (888) 888
adenine - administration & dosage (882) 882
gastroenterology & hepatology (860) 860
antiretroviral drugs (841) 841
viral load (836) 836
aids/hiv (830) 830
hepatitis b virus (790) 790
organophosphonates - administration & dosage (776) 776
hiv infections - virology (769) 769
risk factors (764) 764
safety (749) 749
adenine - adverse effects (735) 735
hepatitis (730) 730
care and treatment (726) 726
deoxycytidine - analogs & derivatives (718) 718
hiv-1 - drug effects (718) 718
young adult (709) 709
entecavir (705) 705
aids (698) 698
virus diseases (676) 676
analysis (665) 665
tenofovir - therapeutic use (650) 650
highly active antiretroviral therapy (643) 643
organophosphonates - adverse effects (625) 625
dosage and administration (614) 614
efavirenz (614) 614
pharmacokinetics (612) 612
hiv infections - complications (586) 586
infections (584) 584
efficacy (580) 580
disoproxil fumarate (579) 579
lamivudine - therapeutic use (560) 560
reverse transcriptase inhibitors - therapeutic use (557) 557
clinical trials (551) 551
animals (547) 547
acquired immune deficiency syndrome--aids (543) 543
patients (539) 539
adolescent (537) 537
double-blind (533) 533
hiv-1 (518) 518
drug resistance (517) 517
risk (511) 511
drug resistance, viral (504) 504
human-immunodeficiency-virus (496) 496
drug combinations (492) 492
aged (489) 489
medical research (476) 476
retrospective studies (475) 475
pregnancy (471) 471
antiretroviral agents (465) 465
mutation (463) 463
cd4 lymphocyte count (456) 456
medicine (449) 449
human immunodeficiency virus (448) 448
adefovir dipivoxil (445) 445
viruses (445) 445
guanine - analogs & derivatives (442) 442
adenine - pharmacology (434) 434
medicine, general & internal (427) 427
anti-hiv agents - pharmacology (422) 422
chronic hepatitis b (418) 418
antiretroviral therapy, highly active (412) 412
drugs (410) 410
more...
Library Location Library Location
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (8896) 8896
Korean (133) 133
Spanish (125) 125
French (85) 85
German (74) 74
Chinese (27) 27
Hungarian (20) 20
Japanese (14) 14
Portuguese (13) 13
Turkish (11) 11
Czech (8) 8
Italian (7) 7
Dutch (3) 3
Polish (3) 3
Russian (3) 3
Indonesian (2) 2
Arabic (1) 1
Croatian (1) 1
Hebrew (1) 1
Persian (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Journal of pharmaceutical and biomedical analysis, ISSN 0731-7085, 2018, Volume 156, pp. 163 - 169
[Display omitted] •An LC–MS/MS method for measurement of TAF and TFV in human plasma and CSF was developed.•The method is fully validated to simultaneously... 
Tenofovir | Plasma | Cerebrospinal fluid | Tenofovir alafenamide | Mass spectrometry | CHEMISTRY, ANALYTICAL | LABELED INTERNAL STANDARDS | ELVITEGRAVIR | EMTRICITABINE | IMPLEMENTATION | HUMAN-IMMUNODEFICIENCY-VIRUS | TANDEM MASS-SPECTROMETRY | REVERSE-TRANSCRIPTASE INHIBITOR | PHARMACOKINETICS | PRODRUG | PHARMACOLOGY & PHARMACY | SIMULTANEOUS QUANTIFICATION | Elvitegravir, Cobicistat, Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination - analysis | HIV Infections - blood | HIV Infections - cerebrospinal fluid | Elvitegravir, Cobicistat, Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination - therapeutic use | Emtricitabine - therapeutic use | Reproducibility of Results | Adenine - analogs & derivatives | Tenofovir - therapeutic use | Humans | Adenine - analysis | Chromatography, High Pressure Liquid | Anti-HIV Agents - analysis | Tandem Mass Spectrometry | Adenine - therapeutic use | Emtricitabine - analysis | Tenofovir - analogs & derivatives | Quinolones - analysis | Quinolones - therapeutic use | Solid Phase Extraction | Tenofovir - analysis | Cobicistat - analysis | HIV Infections - drug therapy | Cobicistat - therapeutic use | Drug Combinations | Antiviral agents | Ionization | Analysis | Pharmacy | Formic acid | Nitriles | Liquid chromatography | Organic acids | mass spectrometry | tenofovir alafenamide | plasma | tenofovir | cerebrospinal fluid
Journal Article
Pharmaceutical research, ISSN 1573-904X, 2017, Volume 34, Issue 12, pp. 2749 - 2755
Journal Article
Journal Article
Clinical Infectious Diseases, ISSN 1058-4838, 02/2016, Volume 62, Issue 3, pp. 375 - 382
Journal Article
Drug safety, ISSN 0114-5916, 04/2017, Volume 40, Issue 4, pp. 273 - 283
Available evidence supports the efficacy of pre-exposure prophylaxis (PrEP) in decreasing the incidence of human immunodeficiency virus (HIV) infection among... 
HIV Infections | Tenofovir | Animals | Humans | Anti-HIV Agents | Review | Journal Article | Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination | Pre-Exposure Prophylaxis | Medicine & Public Health | Drug Safety and Pharmacovigilance | Pharmacology/Toxicology | PHARMACOLOGY & PHARMACY | PUBLIC, ENVIRONMENTAL & OCCUPATIONAL HEALTH | TOXICOLOGY | Anti-HIV Agents - administration & dosage | HIV Infections - prevention & control | Pre-Exposure Prophylaxis - methods | Tenofovir - adverse effects | Anti-HIV Agents - adverse effects | Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination - administration & dosage | Tenofovir - administration & dosage | Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination - adverse effects | Prevention | Clinical trials | Usage | Drug therapy | HIV infection | Intervention | Renal function | Toxicity | Liver | Prophylaxis | Viruses | Infections | Incidence | Mens health | Hepatitis | Acquired immune deficiency syndrome--AIDS | Vomiting | Human immunodeficiency virus--HIV | Risk assessment | Search engines | Bone density | Safety | Product safety | Drug dosages | Drug use | Monitoring | Emtricitabine | Enzymes | Medical research | Effectiveness | Health risks | Diarrhea | Exposure | Nausea | Pharmacology | Disease control | Disease prevention | Side effects | Disease transmission | Reviews | Bone mineral density | Kidney transplantation | Index Medicus
Journal Article
Clinical Infectious Diseases, ISSN 1058-4838, 08/2015, Volume 61, Issue 4, pp. 572 - 580
Journal Article
Journal Article
Journal Article
The New England journal of medicine, ISSN 1533-4406, 2015, Volume 373, Issue 23, pp. 2237 - 2246
Journal Article